Metabolic Pathway Research · GLP-1 receptor agonist
DulaglutideLong-acting GLP-1 receptor agonist fusion peptide.
An older, established GLP-1 drug useful for completeness in the incretin category.
0 papers·FDA-approved·COA Unverified·0 saved
Vendors
0 vendors / 0 options$0.00–$0.00/mg
| Vendor | Tier | Products / options | Salt | Purity | COA | $/mg |
|---|
Reference
Regulatory Status
USResearch only
EUNot approved
UKResearch only
AUResearch only
Regulatory status may change. Always verify current regulations in your jurisdiction before purchase.